BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29115427)

  • 1. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
    Chen XG; Ma L; Xu JX
    Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
    Wang Q
    Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray.
    Shi Z; Zhou H; Pan B; Lu L; Wei Z; Shi L; Yao X; Kang Y; Feng S
    Mol Med Rep; 2017 Nov; 16(5):7423-7431. PubMed ID: 28944885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling analysis of osteosarcoma cell lines.
    Sun L; Li J; Yan B
    Mol Med Rep; 2015 Sep; 12(3):4266-4272. PubMed ID: 26096802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia.
    Huang J; Liu Z; Sun Y; Zhong Q; Xu L; Ou R; Li C; Chen R; Yao M; Zhang Q; Liu S
    Int J Mol Med; 2018 Feb; 41(2):679-686. PubMed ID: 29207054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key biomarkers involved in osteosarcoma using altered modules.
    Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
    Wang Y; Zhao Q; Lan N; Wang S
    Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Logistic regression analysis for the identification of the metastasis-associated signaling pathways of osteosarcoma.
    Liu Y; Sun W; Ma X; Hao Y; Liu G; Hu X; Shang H; Wu P; Zhao Z; Liu W
    Int J Mol Med; 2018 Mar; 41(3):1233-1244. PubMed ID: 29328361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.